The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of National Surgical Adjuvant Breast and Bowel Project protocol R-03
Abstract
PURPOSE: National Surgical Adjuvant Breast and Bowel Project Protocol R-03 was designed to determine the worth of preoperative chemotherapy and radiation therapy in the management of operable rectal cancer. METHODS: Thus far, 116 patients of an eventual 900 with primary operable rectal cancer have been randomized to receive multimodality therapy to begin preoperatively (59 patients) or identical therapy beginning after curative surgery (57). All patients received seven cycles of 5-fluorouracil (FU)/leucovorin (LV) chemotherapy. Cycles 1 and 4 through 7 used a high-dose weekly FU regimen. In Cycles 2 and 3, FU and low-dose LV chemotherapy was given during the first and fifth week of radiation therapy (5,040 cGy). The preoperative arm (Group 1) received the first three cycles of chemotherapy and all radiation therapy before surgery. The postoperative arm (Group 2) received all radiation and chemotherapy after surgery. Primary study end points included disease-free survival and survival. Secondary end points included local recurrence, primary tumor response to combination therapy, tumor downstaging, and sphincter preservation. RESULTS: Overall treatment-related toxicity was similar in both groups. Although seven preoperative patients had events after randomization that precluded surgery, eight events occurred during an equivalent follow-up period in the postoperative group. No patient was deemed inoperable because of progressive local disease. Sphincter-saving surgery was intended in 31 percent of Group 1 patients and 33 percent of Group 2 patients at the time of randomization. Such surgery was actually performed in 50 percent of the preoperatively treated patients and 33 percent of the postoperatively treated patients. The use of protective colostomy in patients undergoing sphincter-sparing surgery and the development of perioperative complications in all surgical patients were similar in both groups. There was evidence of tumor downstaging in evaluable patients undergoing preoperative therapy, with 8 percent of Group 1 patients having had a pathologic complete response. CONCLUSION: These data do suggest that the preoperative chemotherapy and radiation therapy regimen used are, at least, as safe and tolerable as standard postoperative treatment. There is presently a trend to tumor downstaging and sphincter preservation in the preoperative arm. Whether this arm will have greater or lesser survival and long-term toxicity awaits the completion of this relevant study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Rosen, G., Caparros, B., Huvos, A. G., Kosloff, C., Nirenberg, A., Cacavio, A., Marcove, R. C., Lane, J. M., Mehta, B., & Urban, C. (1982) · Cancer · doi:10.1002/1097-0142(19820315)49:6<1221::aid-cncr2820490625>3.0.co;2-e · Cited by 1,090
Adjuvant Therapy for Patients With Colon and Rectal Cancer
(1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110090034 · Cited by 1,086
Fisher, B., Wolmark, N., Rockette, H., Redmond, C., Deutsch, M., Wickerham, D. L., Fisher, E. R., Caplan, R., Jones, J., Lerner, H., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.21 · Cited by 1,030
Self-citationGÉRARD, A., BUYSE, M., NORDLINGER, B., LOYGUE, J., PÈNE, F., KEMPF, P., BOSSET, J.-F., GIGNOUX, M., ARNAUD, J.-P., DESAIVE, C., et al. (1988) · Annals of Surgery · doi:10.1097/00000658-198811000-00011 · Cited by 665
The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma
Cedermark, B., Johansson, H., Rutqvist, L. E., & The Stockholm Colorectal Cancer Study Group (1995) · Cancer · doi:10.1002/1097-0142(19950501)75:9<2269::aid-cncr2820750913>3.0.co;2-i · Cited by 639
PÅHLMAN, L., & GLIMELIUS, B. (1990) · Annals of Surgery · doi:10.1097/00000658-199002000-00011 · Cited by 574
Frykholm, G. J., Glimelius, B., & Påhlman, L. (1993) · Diseases of the Colon & Rectum · doi:10.1007/bf02049863 · Cited by 538
Hortobagyi, G. N., Ames, F. C., Buzdar, A. U., Kau, S. W., McNeese, M. D., Paulus, D., Hug, V., Holmes, F. A., Romsdahl, M. M., Fraschini, G., et al. (1988) · Cancer · doi:10.1002/1097-0142(19881215)62:12<2507::aid-cncr2820621210>3.0.co;2-d · Cited by 504
Fisher, B., Gündüz, N., & Saffer, E. (1983) · PubMed · Cited by 422
Self-citation
Cited by
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Habr-Gama, A., Perez, R. O., Nadalin, W., Sabbaga, J., Ribeiro, U., Silva e Sousa, A. H., Campos, F. G., Kiss, D. R., & Gama-Rodrigues, J. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000141194.27992.32 · Cited by 1,893
Francois, Y., Nemoz, C. J., Baulieux, J., Vignal, J., Grandjean, J.-P., Partensky, C., Souquet, J. C., Adeleine, P., & Gerard, J.-P. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2396 · Cited by 815
Practice Parameters for the Management of Rectal Cancer (Revised)
Monson, J. R. T., Weiser, M. R., Buie, W. D., Chang, G. J., Rafferty, J. F., Buie, W. D., Rafferty, J., Guillem, J., Boushey, R., Chang, G., et al. (2013) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31828cb66c · Cited by 563
Postoperative Complications Following Surgery for Rectal Cancer
Paun, B. C., Cassie, S., MacLean, A. R., Dixon, E., & Buie, W. D. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181dae4ed · Cited by 515
Bujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., Michalski, W., Bębenek, M., Pudełko, M., Kryj, M., Olędzki, J., Szmeja, J., Słuszniak, J., et al. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2003.12.006 · Cited by 505
Gunderson, L. L., Sargent, D. J., Tepper, J. E., Wolmark, N., O'Connell, M. J., Begovic, M., Allmer, C., Colangelo, L., Smalley, S. R., Haller, D. G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.173 · Cited by 436
Self-citationGerard, J.-P., Chapet, O., Nemoz, C., Hartweig, J., Romestaing, P., Coquard, R., Barbet, N., Maingon, P., Mahe, M., Baulieux, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.170 · Cited by 324
Enker, W. E., Merchant, N., Cohen, A. M., Lanouette, N. M., Swallow, C., Guillem, J., Paty, P., Minsky, B., Weyrauch, K., & Quan, S. H. Q. (1999) · Annals of Surgery · doi:10.1097/00000658-199910000-00010 · Cited by 299
Local Excision of T2 and T3 Rectal Cancers After Downstaging Chemoradiation
Kim, C. J., Yeatman, T. J., Coppola, D., Trotti, A., Williams, B., Barthel, J. S., Dinwoodie, W., Karl, R. C., & Marcet, J. (2001) · Annals of Surgery · doi:10.1097/00000658-200109000-00009 · Cited by 275
A Systematic Overview of Radiation Therapy Effects in Rectal Cancer
Glimelius, B., Grönberg, H., Järhult, J., Wallgren, A., & Cavallin-ståhl, E. (2003) · Acta Oncologica · doi:10.1080/02841860310012301 · Cited by 263
Metadata
- Authors
- Hyams, D. M., Mamounas, E. P., Petrelli, N., Rockette, H., Jones, J., Wieand, S. H., Deutsch, M., Wickerham, L. D., Fisher, B., & Wolmark, N.
- Venue
- Diseases of the Colon & Rectum
- Published
- 1997-02
- Volume
- 40
- Issue
- 2
- Pages
- 131-139
- ISSN
- 0012-3706 (ISSN-L)
- OpenAlex
- W2792447334
- Cited by
- 360
- References
- 20
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.